Skip to main content

Teleflex Value Stock - Dividend - Research Selection

Teleflex

ISIN: US8793691069, WKN: 855853

Market price date: 20.07.2021
Market price: 386,15 USD




Teleflex Fundamental data and company key figures of the share

Annual reports in USD
Key figures 19-04-2021
Cash flow
Net operating cash flow 437.143.000
Capital Expenditures -90.694.000
Free cash flow 346.448.992
Balance sheet
Total Equity 3.336.460.000
Liabilities & Shareholders equity 7.152.560.000
Income statement
Net income 335.324.000
Eps (diluted) 7,090
Diluted shares outstanding 46.680.000
Net sales/revenue 2.537.160.000

Fundamental ratios calculated on: 20-07-2021

Ratios
Key figures 20-07-2021
Cash flow
P/C 41,24
   
P/FC 52,03
Balance sheet
ROI4,69
ROE46,65
Income statement
P/E54,46
Div. Yield0,00%
P/B5,40
P/S7,11


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolTFX
Market Capitalization18.025.482.240,00 USD
Country
IndicesNO INDEX
Sectors
Raw Data SourceUS GAAP in Millionen USD
Stock Split1997-06-17,2.000000/1.000000; 1991-06-17,3.000000/2.000000; 1986-06-17,2.000000/1.000000; 1981-09-16,3.000000/2.000000; 1980-12-16,2.000000/1.000000; 1978-06-16,2.000000/1.000000
Internetwww.teleflex.com


Description of the company

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.teleflex.com